Business Description

Rhythm Biosciences Ltd
ISIN : AU000000RHY2
Description
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 49.05 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.01 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -15.2 | |||||
3-Year EPS without NRI Growth Rate | -2.8 | |||||
3-Year FCF Growth Rate | -11.2 | |||||
3-Year Book Growth Rate | 19.1 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.51 | |||||
9-Day RSI | 37.15 | |||||
14-Day RSI | 38.36 | |||||
6-1 Month Momentum % | -24.24 | |||||
12-1 Month Momentum % | -68.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.03 | |||||
Quick Ratio | 2.46 | |||||
Cash Ratio | 2.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -23.9 | |||||
Shareholder Yield % | -2.97 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -111.85 | |||||
ROA % | -94.18 | |||||
ROIC % | -895.19 | |||||
ROC (Joel Greenblatt) % | -1849.68 | |||||
ROCE % | -155 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 11.48 | |||||
Price-to-Tangible-Book | 10.33 | |||||
EV-to-EBIT | -5.78 | |||||
EV-to-EBITDA | -5.87 | |||||
EV-to-FCF | -9.45 | |||||
Price-to-Net-Current-Asset-Value | 15.5 | |||||
Price-to-Net-Cash | 31 | |||||
Earnings Yield (Greenblatt) % | -17.3 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rhythm Biosciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | |||
EPS (TTM) (A$) | -0.038 | ||
Beta | 2.77 | ||
Volatility % | 52.58 | ||
14-Day RSI | 38.36 | ||
14-Day ATR (A$) | 0.028008 | ||
20-Day SMA (A$) | 0.34675 | ||
12-1 Month Momentum % | -68.62 | ||
52-Week Range (A$) | 0.3 - 1.31 | ||
Shares Outstanding (Mil) | 221.14 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Rhythm Biosciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Rhythm Biosciences Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Rhythm Biosciences Ltd Frequently Asked Questions
What is Rhythm Biosciences Ltd(ASX:RHY)'s stock price today?
The current price of ASX:RHY is A$0.34. The 52 week high of ASX:RHY is A$1.31 and 52 week low is A$0.30.
When is next earnings date of Rhythm Biosciences Ltd(ASX:RHY)?
The next earnings date of Rhythm Biosciences Ltd(ASX:RHY) is .
Does Rhythm Biosciences Ltd(ASX:RHY) pay dividends? If so, how much?
Rhythm Biosciences Ltd(ASX:RHY) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |